All Stories

  1. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis
  2. A brief survey of interventional agents intended to treat Long COVID
  3. Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration
  4. What is the place of naturalistic philosophy in the doing of science? Implications for the teaching of science
  5. The Climate Fix: make what’s important measurable …
  6. In the doing of science, what is the place for naturalistic philosophy? Implications for the teaching of science
  7. Occupation from a perspective of complementarity - Part 2 - Proposals for situating a complementarity perspective in occupational science
  8. Occupation from a perspective of complementarity - Part 1 - Background to the development of a concept
  9. Occupation from a perspective of complementarity - Part 2 - Proposals for situating a complementarity perspective in occupational science
  10. A preliminary investigation of what occupational science is doing
  11. Restoring Australia’s long-term innovation requires investment in basic research
  12. On the ongoing need for naturalistic philosophy to interpret what occupational science is doing
  13. “We Ourselves Are Both Actors and Spectators”: What is the Place of Naturalistic Philosophy in the Doing of Science? Implications for the Teaching of Science
  14. Review of: "Naturalism's maxims and its methods. Is naturalistic philosophy like science?"
  15. “Elements of My Life”
  16. Risk Factors for Heart Disease in Working Railwaymen
  17. Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP)
  18. Cat in Trinity Lane, Cambridge, 2010
  19. A Pair of Floating Microscopes: Transformation by Reflection
  20. A Left-Handed Pillar Box
  21. Antiinflammatory and Anticancer Properties of Grewia asiatica Crude Extracts and Fractions: A Bioassay-Guided Approach
  22. Lunar Eclipse, May 26, 2021
  23. Phytochemical Profile, Biological Properties, and Food Applications of the Medicinal Plant Syzygium cumini
  24. The Chemical Composition and Health-Promoting Effects of the Grewia Species—A Systematic Review and Meta-Analysis
  25. From Engineer to Artist: “Who Is the Potter, Pray, and Who the Pot?”
  26. Kookaburras on the Clothes Line, Backyard, Queensland
  27. In silico molecular dynamics of human glycophorin A (GPA) extracellular structure
  28. Syzygium cumini(L.),Skeels fruit extracts: In vitro and in vivo anti-inflammatory properties
  29. The interaction between Glycophorin A (GPA) and Band 3 in the formation of the Wright b (Wrb) antigen
  30. Tyrosinase inhibitors as potential antibacterial agents
  31. Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies
  32. Editorial
  33. From Generation to Generation
  34. The Zone of Inhibition
  35. Serendipity in Science: The Unexpected Tie
  36. Discrimination and Social Justice: Questions of Diversity, Plurality, Representativeness, Measurability, and Doublespeak
  37. The Bay of Marseille, Viewed from L'Estaque, 2010
  38. Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017)
  39. “Baby” Microscope
  40. Nicotiana tabacum, or the Letter “Aleph” with 22 Flowers
  41. Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other Medicines
  42. A Shark–Human Chimera
  43. Development of a Multiplexed Microsphere PCR for Culture-Free Detection and Gram-Typing of Bacteria in Human Blood Samples
  44. Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
  45. Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells
  46. A New Clade of Insect-Specific Flaviviruses from Australian Anopheles Mosquitoes Displays Species-Specific Host Restriction
  47. Characterization of the banana streak virus capsid protein and mapping of the immunodominant continuous B-cell epitopes to the surface-exposed N terminus
  48. Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles
  49. A New Orbivirus Isolated from Mosquitoes in North-Western Australia Shows Antigenic and Genetic Similarity to Corriparta Virus but Does Not Replicate in Vertebrate Cells
  50. CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses
  51. Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia
  52. Commensal Viruses of Mosquitoes: Host Restriction, Transmission, and Interaction with Arboviral Pathogens
  53. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars
  54. A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia
  55. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
  56. RNA and DNA Diagnostics on Microspheres: Current and Emerging Methods
  57. Genotyping of Campylobacter jejuni using a novel Polymerase-Chain-Reaction-Microsphere approach
  58. Application of the PrimRglo Assay Chemistry to Multiplexed Bead Assays
  59. Effects of magnesium deficiency – More than skin deep
  60. Multi-locus sequence typing of Campylobacter jejuni using a novel polymerase-chain-reaction-microsphere method
  61. Interdisciplinary science research and education
  62. Gene expression phenotypes for lipid metabolism and intramuscular fat in skeletal muscle of cattle1
  63. A New, Multiplex, Quantitative Real-Time Polymerase Chain Reaction System for Nucleic Acid Detection and Quantification
  64. Multiplex–microsphere–quantitative polymerase chain reaction: Nucleic acid amplification and detection on microspheres
  65. Recombinant Vaccines: Development, Production, and Application
  66. PrimRglo: A multiplexable quantitative real-time polymerase chain reaction system for nucleic acid detection
  67. Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle
  68. Expecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
  69. Chapter 2 Complexity and mastery in shaping interdisciplinarity
  70. Molecular Phylogeny of Edge Hill Virus Supports its Position in the Yellow Fever Virus Group and Identifies a New Genetic Variant
  71. Recombinant vaccines
  72. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
  73. Detection of Influenza A Virus Neuraminidase and PB2 Gene Segments by One Step Reverse Transcription Polymerase Chain Reaction
  74. University biotechnology education in Australia in an international context
  75. A broad spectrum, one-step reverse-transcription PCR amplification of the neuraminidase gene from multiple subtypes of influenza A virus
  76. Genomic characterisation of Wongabel virus reveals novel genes within the Rhabdoviridae
  77. Universal primers that amplify RNA from all three flavivirus subgroups
  78. Interdisciplinarity and Interprofessionalism: Implications for Biotechnology Education
  79. Use of Chimeric Antibodies as Positive Controls in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Scrub Typhus (Infection by Orientia tsutsugamushi)
  80. Reply to Herrera and Ruiz-Opazo's letter published in the June 2006 issue
  81. A1079T transversion in the gene for the α1 isophorm of the Na+/K+ ATPase in the Dahl S rat
  82. Development of an Oligonucleotide-Based SNP Detection Method on Lateral Flow Strips Using Hexapet Tags
  83. Chimerization of multiple antibody classes using splice overlap extension PCR
  84. The ''parallel bridge'' and its relevance to biotechnology new ventures
  85. Towards definition of the global biotechnology value chain using cases from Australian biotechnology SMEs
  86. Valuing of firms' prior knowledge: a measure of knowledge distance
  87. Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene
  88. GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study
  89. Placental Growth Hormone Is Not Suppressed by Oral Glucose Loading in Normal Human Pregnancy
  90. Neither the New Zealand Genetically Hypertensive Strain nor Dahl Salt-Sensitive Strain Has an A1079T Transversion in the α1 Isoform of the Na + ,K + -ATPase Gene
  91. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  92. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  93. Comparison of Competitively Primed and Conventional Allele-Specific Nucleic Acid Amplification
  94. Placental Growth Hormone (GH), GH-Binding Protein, and Insulin-Like Growth Factor Axis in Normal, Growth-Retarded, and Diabetic Pregnancies: Correlations with Fetal Growth
  95. True
  96. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring
  97. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure
  98. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response
  99. Analysis and Application of an Equilibrium Model forin vitroBioassay Systems with Three Components: Receptor, Hormone and Hormone-Binding-Protein
  100. Expression of Growth Hormone Receptors by Lymphocyte subpopulations in the Human tonsil
  101. Growth Hormone-Binding Protein in Normal and Pathologic Gestation: Correlations with Maternal Diabetes and Fetal Growth1
  102. Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: A role for GH in early embryogenesis?
  103. The serum growth hormone binding protein: pregnant with possibilities
  104. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems
  105. Upregulation of GH receptor and GH binding protein during pregnancy in the GH deficient rat
  106. A Growth Hormone Agonist Produced by Targeted Mutagenesis at Binding Site 1.
  107. Measurement of growth hormone-binding protein in the rat by a ligand immunofunctional assay
  108. Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor.
  109. Evidence for Involvement of the Carboxy Terminus of Helix 1 of Growth Hormone in Receptor Binding: Use of Charge Reversal Mutagenesis to Account for Calcium Dependence of Binding and for Design of Higher Affinity Analogs
  110. Selective inhibition of mouse placental lactogen II secretion by tumour necrosis factor-α
  111. Signal Transduction by the Growth Hormone Receptor
  112. The search for receptor-interactive regions in growth hormone: historical perspectives and novel strategies
  113. Expression of growth hormone-binding protein with a hydrophilic carboxyl terminus by the mouse placenta: studies in vivo and in vitro
  114. Growth hormone receptor and growth hormone-binding protein messages in mouse placenta contain the exon analogous to human exon 3
  115. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system
  116. A strategy for optimizing charge reversal mutagenesis of ion pairs in hormone—receptor or enzyme—substrate complexes
  117. The first disulphide loop of the rabbit growth hormone receptor is required for binding to the hormone
  118. Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse
  119. A mouse growth hormone-binding protein RIA: concentrations in maternal serum during pregnancy.
  120. Growth Hormone (GH) Receptors in Clonal Osteoblast Like Cells Mediate a Mitogenic Response to GH*
  121. Visual Demonstration of Growth Hormone Receptors on Human Growth Plate Chondrocytes*
  122. Soluble forms of the rabbit adipose tissue and liver growth hormone receptors are antigenically identical, but the integral membrane forms differ
  123. Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies
  124. An electrostatic model for the interaction between growth hormone and its receptor involving chelation of Ca2+ to the human growth hormone molecule
  125. The Ontogeny of Growth Hormone Receptors in the Rabbit Tibia*
  126. Use of calcium dependence as a means to study the interaction between growth hormones and their binding proteins in rabbit liver
  127. Growth hormone receptor and serum binding protein: purification, cloning and expression
  128. Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane ‘receptor’ types 1 and 2
  129. Evidence for Differential Binding of Growth Hormones to Membrane and Cytosolic GH Binding Proteins of Rabbit Liver
  130. Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor
  131. Monoclonal Antibodies to the Rabbit Liver Growth Hormone Receptor: Production and Characterization*
  132. Use of serum copper/zinc ratio in patients with large bowel cancer
  133. Tennessee antigen
  134. Tennessee antigen
  135. Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer
  136. VALUE OF SERIAL CARCINOEMBRYONIC ANTIGEN DETERMINATIONS FOR EARLY DETECTION OF RECURRENT CANCER
  137. Diagnostics development for clinical and research settings